Am J Psychiatry

1. ENWRIGHT JF 3RD, Tamburino AM, Tumkaya T, Lovatt D, et al
   Transcriptional Profiles of Somatostatin and Parvalbumin Interneuron Subtypes in the Human Dorsolateral Prefrontal Cortex: Implications for Schizophrenia.
   Am J Psychiatry. 2026 Apr 22:appiajp20250355. doi: 10.1176/appi.ajp.20250355.
   

   >> Share

   
   

   
   Biol Psychiatry

2. RODRIGUEZ-SANCHEZ J, Hauke DJ, Pinotsis D, Berndt LCS, et al
   Biophysical modeling of excitation/inhibition balance and conversion to psychosis in the clinical high risk syndrome.
   Biol Psychiatry. 2026 Apr 21:S0006-3223(26)01191.
   

   >> Share

   
   

   
   Br J Psychiatry

3. FERNANDEZ-EGEA E, Garcia-Rizo C, Kirkpatrick B
   Schizophrenia and accelerated ageing: systematic review and future research directions.
   Br J Psychiatry. 2026 Apr 22:1-13. doi: 10.1192/bjp.2026.10606.
   

   >> Share

   
   

   
   Mol Psychiatry

4. NUSSBAUMER M, Guest PC, Schiltz K, Dudeck L, et al
   Multimodal microglial and kynurenine pathway alterations across the affective-psychosis spectrum: a systematic review of patterns, heterogeneity, and dimensional implications.
   Mol Psychiatry. 2026 Apr 21. doi: 10.1038/s41380-026-03614.
   

   >> Share

   
   
5. CAO L, Maleki Balajoo S, Gao Y, Li H, et al
   Common alterations of whole and subregion-specific amygdala intrinsic functional connectivity across psychiatric disorders: a meta-analysis.
   Mol Psychiatry. 2026;31:2916-2926.
   

   >> Share

   
   

   
   Psychiatry Res

6. HU G, Wei D, Zhang J, Liu J, et al
   Corrigendum to "Effect of computerized cognitive remediation therapy combined with individualized occupational therapy on cognitive function and functional outcomes in patients with schizophrenia: A randomized controlled trial" [Psychiatry Research 35
   Psychiatry Res. 2026 Apr 20:117166. doi: 10.1016/j.psychres.2026.117166.
   

   >> Share

   
   
7. KIM KH, Kim C, Song I, Kim DS, et al
   Nationwide trends in antipsychotic and co-medication prescribing for schizophrenia: analysis of National Health Insurance data (2011-2023).
   Psychiatry Res. 2026;361:117159.
   

   >> Share

   
   
8. HIRA S, Ozcan O, Ipcioglu OM, Hatipoglu M, et al
   Impaired central methylation capacity in drug-naive first-episode psychosis: Evidence from cerebrospinal fluid one-carbon metabolism.
   Psychiatry Res. 2026;361:117169.
   

   >> Share

   
   

   
   Schizophr Res

9. CHENG L, Xu X, Yang H, Du J, et al
   A multimodal fNIRS-based machine learning model for symptom assessment and treatment response prediction in schizophrenia.
   Schizophr Res. 2026;294:63-72.
   

   >> Share

   
   
10. WEI Y, Huang Y, Cui H, Xu L, et al
    Cross-disorder brain morphological similarity in schizophrenia: Associations with symptom severity and treatment outcome.
    Schizophr Res. 2026;294:52-62.
    

    >> Share

    
    
11. HARVEY PD, Kaul I, Chataverdi S, Patel T, et al
    Effects of Xanomeline and Trospium Chloride for Negative Symptoms Associated With Physical Activity in Younger and Older Adults with Schizophrenia: Results From a 52-Week, Open-label Clinical Trial.
    Schizophr Res. 2026;294:44-51.
    

    >> Share

    
    
12. LIN CE, Chen LF, Sack AT, Chang HA, et al
    Task-based fNIRS biomarkers of HD-tDCS treatment for negative symptoms in schizophrenia.
    Schizophr Res. 2026;294:35-43.
    

    >> Share

    
    
13. JANSSEN H, van den Berg KC, Keijsers GPJ, Marcelis MC, et al
    Associations between characteristics of emotional mental imagery and auditory verbal hallucinations in individuals with psychosis spectrum disorders.
    Schizophr Res. 2026;294:27-34.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share